Lifecore Biomedical Inc. (LFCR) — Long-term Investment Intensity
Lifecore Biomedical Inc. (LFCR) has a Long-term Investment Intensity of 9.0% as of May 2021. Long-term investments of $45.10 Million represent 9.0% of total assets of $502.92 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See net assets of Lifecore Biomedical Inc. for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Lifecore Biomedical Inc. Long-term Investment Intensity (2019–2021)
This chart shows how Lifecore Biomedical Inc.'s Long-term Investment Intensity has evolved across 3 annual periods from 2019 to 2021. As of May 2021, the intensity stands at 9.0%, reflecting long-term investments of $45.10 Million against total assets of $502.92 Million USD. Also explore balance sheet size of Lifecore Biomedical Inc. for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Lifecore Biomedical Inc. (2019–2021)
The table below presents the year-by-year Long-term Investment Intensity for Lifecore Biomedical Inc. from 2019 to 2021, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market value of Lifecore Biomedical Inc..
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2021 | 9.0% | $45.10 Million | $502.92 Million | ▼ -1.5 pp |
| 2020 | 10.5% | $56.90 Million | $541.31 Million | ▼ -1.3 pp |
| 2019 | 11.8% | $61.10 Million | $519.09 Million | — |